Daily Archives: 18/10/2010

Daily IP News: 18/10/2010

1) Biocon and Pfizer Enter Into Global Commercialization Agreement (Pfizer Press Release). Pfizer will have exclusive license to commercialize biocon’s biosimilar versions of Recombinant Human Insulin, Glargine , Aspart and Lispro (all are long/fast acting insulin analogs). … Under the terms of the … Continue reading

Posted in Daily interesting IP news | Leave a comment